Abstract:Objective: To explore the therapeutic effect of combined 595?nm pulsed dye laser and fractional CO? laser on severe hypertrophic scars. Methods: Ninety?two patients enrolled from March 2023 to March 2026 were randomly divided into a control group (n=46, fractional CO? laser monotherapy) and a study group (n=46, combined 595?nm pulsed dye laser therapy). Clinical efficacy, serological indicators, scar severity, quality?of?life scores, recurrence rate and adverse reactions were compared between groups. Results: The overall response rate was higher in the study group than in the control group (P < 0.05); VEGF and TGF-β1 levels, as well as VSS scores, decreased in both groups after treatment, with more significant reductions observed in the study group (P < 0.05); Quality of life improved in both groups, with the study group showing greater improvement (P < 0.05); there was no difference in the incidence of adverse reactions (P > 0.05), and the recurrence rate in the study group was lower than that in the control group (P < 0.05). Conclusion: Combined 595?nm pulsed dye laser and fractional CO? laser exerts synergistic effects on hypertrophic scars. This safe and effective regimen improves therapeutic outcomes, lowers recurrence, facilitates recovery and enhances patients’ quality of life.